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• Maternal diet is critical for a successful pregnancy and desirable fetal health 
outcomes. Recent investigations reveal that dietary fats, such as omega-3 
fatty acids, serve as substrates for the biosynthesis of specialized pro-
resolving lipid mediators (SPM), which have anti-inflammatory and immune-
stimulating effects. 
• Obesity-associated inflammation in early development may have lifelong 
impacts on the offspring. Studies are needed to identify modifiable factors 
that can reduce inflammation and limit the negative consequences of 
obesity during pregnancy. Recent studies reveal certain omega-3 fatty acid 
derivatives actively attenuate and resolve pro-inflammatory processes. 
• These SPMs may be key to the beneficial effects of omega-3 fatty acids. 
While the association between inflammation and obesity is clear, the 
protective mechanisms of SPMs against complicated birth in maternal-fetal 
health are a gap in the field.
Current Understanding
• It is known that SPM production is dependent on intermediates of the 
omega-3 fatty acid metabolic pathway. However, the relationship between 
maternal omega-3 fatty acid intake and maternal and cord plasma SPM 
levels in normal weight versus obese pre-pregnancy body mass index 
(BMI) deliveries is unclear. In recent studies, the Anderson Berry Lab has 
found strikingly low intakes of omega-3 fatty acids in pregnant woman. 
• Thus, understanding the therapeutic value of omega-3 fatty acid intake 
and the role of SPMs in maternal-fetal outcomes addresses an unmet 
need. 
• We hope to achieve two specific aims: 1) to identify the relationship 
between maternal omega-3 fatty acid intake and maternal and cord 
plasma SPM levels in normal weight pre-pregnancy BMI and obese pre-
pregnancy BMI deliveries and 2) to evaluate similarities and differences in 
intakes, food security, and transportation security. 
In Vitro Expression of SPM Receptors
Methods
Figure 1. Preliminary Results A. GPR18 expression in placental
trophoblast cells (HTR-8 and JEG-3). Cells were stained with anti-GPR-18
antibody (green) and nuclei were stained with DAP1. GPR18 expression in
testicular cells (NETRA) and placental trophoblast cells were predominantly
in cytoplasm. B. RvD1 (panel A) and RvD2 (panel B) concentrations in
maternal and cord plasma at delivery. P<0.001 for both. C. RvD1 (panel A)
and RvD2 (panel B) concentrations in maternal plasma with and without
infant NICU administration. P = 0.03 for RvD1, p = 0.003 for RvD2.
Future Direction
Conclusion
• Very little is known about the independent biological activity of dietary fats, 
but our findings demonstrate their possible impact on fetal outcomes.
• Further study is warranted to explore the impacts omega-3 fatty acids and 
SPMs have on both maternal and infant outcomes.
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Introduction
• We plan to employ a targeted lipidomics 
approach (liquid chromatography-tandem 
mass spectrometry-mediated lipid 
identification) to measure SPM levels and 
determine the association between maternal 
omega-3 fatty acid dietary intake and 
maternal and cord plasma SPM levels.
• Clinical and dietary data from 80 existing 
samples (40 mother-infant pairs) consisting 
of maternal, cord, placental, and neonatal 
blood and breast milk, 32% of which had a 
pre-pregnancy BMI >30 will be analyzed.
• Key lipids and metabolites to be 
characterized will include 18- HEPE, 15-
HETE, RvE1, RvD1, RvD2, RVD3, RvD5, 
17(R)-RvD1, Maresin-1, and protectin-D1. 
This technique will also allow for 
determination of the association between 
maternal and cord serum concentrations of 
SPMs of obese pre-pregnancy BMI delivery. 
Levels and associations with clinical 
pregnancy outcomes will be analyzed.
Recruitment
• Over a 10-week period, the collection of informed 
consent, preparation of maternal and cord blood, 
preparation of placental tissue samples, and 
administration of a validated food frequency 
questionnaire was completed.
Data Collection
• Over 100 new subjects were successfully enrolled in the 
study. Preliminary evaluation of differences in intakes, 
food security, and transportation security between obese 
and normal weight groups was completed.
Evaluation
• Utilization of a targeted lipidomics approach to measure 
SPMs and determine the association between maternal 
omega-3 fatty acid dietary intake and maternal and cord 
plasma SPMs is in progress. 
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